Voyageur is focused on moving its proven NI-43-101 barium sulfate (“barite”) resource of high purity barite into cash flow by manufacturing barium contrast suspension products (X-Ray, CT-Scan & MRI applications). Voyageur is implementing a strategy to control its own  supply chain and all input costs FROM THE  EARTH TO THE BOTTLE.

Barium contrast is the highest value barite in the industrial market.

• One of a kind deposit. Currently has 166,210 tonnes indicated and 95,578 tonnes inferred of barium sulfate resource suitable for the pharmaceutical and paint grade markets (Source: Voyageur NI 43-101).
• Voyageur’s Pharmaceuticals Inc is moving  forward with Health Canada and FDA  registration of our products.
• The January 2019 price for  pharmaceutical  barite used in contrast, delivered to Calgary was CAD$ 5,000/tonne. PC B. Willis, 2018, direct cost from supplier for barite landed at Calgary manufacturing plant.
• The primary uses for high purity barite include paints, pharmaceuticals, and many other niche markets. The pharmaceutical barite is used for contrast media suspension for the X-ray, CT-Scan and MRI applications.
• Barite makes up 98% of the ingredients in dry contrast. The producer of contrast with lowest barite costs will be the most competitive.  This allows Voyageur a great advantage as we own our own barite source. At the present time there are NO producing pharmaceutical high-grade barite mines in Canada or the US.

Voyageur`s Frances Creek Barite tested as highest purity for natural occurring barite with grades between 96.5% and 99.5%  BaSO₄ – with a specific gravity between 4.3-4.5.sg. Classified as industrial grade.

• There are no other high grade Industrial-Grade barite mines producing in Canada and the USA.
• Our high grade barite will allow us to penetrate a bull market that is 100% reliant on imports.
• Voyageur’s  production has potential to provide a high rate of return for investors.
• The demand for pharmaceutical barite is increasing worldwide as the population increases.
• The opportunity to participate in this rising bull market in pharmaceutical barite is rare and exciting.